By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Poolbeg Pharma PLC

Poolbeg Pharma PLC (POLB.L)

LSE Currency in GBP
£3.15
£0.00
0.00%
Last Update: 16 Jul 2025, 15:36
£15.75M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£2.25 - £13.50
52 Week Range

POLB.L Stock Price Chart

Explore Poolbeg Pharma PLC interactive price chart. Choose custom timeframes to analyze POLB.L price movements and trends.

There is nothing to show.

POLB.L Company Profile

Discover essential business fundamentals and corporate details for Poolbeg Pharma PLC (POLB.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

19 Jul 2021

Employees

15.00

CEO

Jeremy Skillington

Description

Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class intranasally administered RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

POLB.L Financial Timeline

Browse a chronological timeline of Poolbeg Pharma PLC corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 May 2026

Upcoming earnings on 16 Sept 2025

Earnings released on 20 May 2025

Earnings released on 18 Sept 2024

EPS came in at -£4.52 falling short of the estimated -£0.00 by -100.26K%.

Earnings released on 30 Apr 2024

EPS came in at -£4.28.

Earnings released on 13 Sept 2023

EPS came in at -£3.62.

Earnings released on 30 Mar 2023

EPS came in at -£6.16.

Earnings released on 6 Sept 2022

EPS came in at -£3.21 falling short of the estimated -£0.00 by -100.34K%.

Earnings released on 31 Dec 2021

EPS came in at -£2.34.

Earnings released on 30 Jun 2021

EPS came in at -£2.34.

POLB.L Stock Performance

Access detailed POLB.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
POLB.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
POLB.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More